KMDA
NASDAQ
$7.09
Kamada Ltd (KMDA)
Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
Sector:
Healthcare
Buy
Target: $13 (+83.36%)
Market Cap
$422M
Forward P/E
16.72
P/E Ratio
20.56
Free Cash Flow Yield
3.92%
Price Chart
Valuation
Market Cap$422M
P/E20.56
Forward P/E16.72
PEG1.03
P/S2.31
P/B1.59
Profitability
Total Revenue (TTM)$182M
Gross Profit (TTM)$75M
EBITDA$38M
Profit Margin9.1%
Operating Margin15.4%
EPS$0.35
Financial Health
Debt-to-Equity4.5%
Free Cash Flow Yield3.92%
Dividend Yield3.55%
Growth & Risk
EPS 5Y CAGR-0.13%
Revenue 5Y CAGR+7.79%
FCF 5Y CAGR-2.88%
Beta (5Y)0.82
Sharpe Ratio0.00